(Press-News.org) Lisa Rotenstein, MD, of the Department of Medicine at Brigham and Women’s Hospital, is the lead author of a new study published in JAMA Network Open, “Virtual Scribes and Physician Time Spent on Electronic Health Records.”
What question were you investigating?
We sought to understand the impact of virtual scribes (human scribes who are not physically present in the exam room with the physician and patient) on how physicians spend their time and which characteristics are associated with physicians responding best to scribes.
What methods or approach did you use?
We studied the experiences of 144 physicians across specialties treating patients in the outpatient setting at Massachusetts General Hospital and Brigham and Women’s Hospital. We looked at physicians who had used a scribe for at least three months from January 2020 to September 2022. Since 2017, both hospitals have experimented with using real-time or asynchronous virtual scribe services.
What did you find?
We found that use of virtual scribes was associated with physicians spending significantly less time in the electronic health record in total, on notes, and after-hours. Physicians with the following characteristics had the greatest reductions in electronic health records time upon scribe use: medical specialists, those physicians who started out spending the most time on their notes, and physicians who had the greatest reduction in how much they contributed to the note.
What are the implications and next steps?
These findings suggest that virtual scribes may be valuable tools for health systems looking to reduce the burden of the electronic health record for physicians. They also provide insight into which physicians may most benefit from virtual scribes, or in the future, AI-powered scribes.
Authorship: In addition to Rotenstein, Mass General Brigham authors include Christine Iannaccone (BWH), Jianyi Zhang (BWH), Aqsa Mugal (BWH), Stuart R. Lipsitz (BWH), Michael J. Healey (BWH), Christopher Holland, Richard Snyder, David Ting (MGH), and David W. Bates (BWH). Additional authors include Edward R. Melnick and Christine A. Sinsky.
Paper cited: Rotenstein L et al. “Virtual Scribes and Physician Time Spent on Electronic Health Records” JAMA Network Open DOI: 10.1001/jamanetworkopen.2024.13140
END
Research spotlight: Virtual scribes reduced physicians’ time spent on electronic health records
2024-05-24
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Duke-NUS researchers develop new light-controlled ‘off switch’ for brain cells
2024-05-24
Researchers from Duke-NUS Medical School have found that a new class of light-sensitive proteins are capable of turning off brain cells with light, offering scientists an unprecedentedly effective tool to investigate brain function. The study, recently published in Nature Communications, opens exciting new opportunities to apply optogenetics to investigate the brain activity underlying neurodegenerative and psychiatric disorders such as Parkinson’s disease and depression.
Optogenetics is a technique where specific cells are bioengineered to include light-sensitive proteins that act as switches, allowing ...
Liver lesions at risk of transformation into hepatocellular carcinoma in cirrhotic patients
2024-05-24
Hepatocellular carcinoma (HCC) represents a significant global health burden as one of the most common malignancies in individuals with chronic liver disease or cirrhosis. This malignancy evolves through a multistep process, beginning with dysplastic nodules (DNs) and early HCC, progressing to overt HCC. Recent advancements in liver imaging, particularly the use of hepatocyte-specific contrast agents, have enhanced the detection of these precursor lesions, known as borderline hepatic nodules. These nodules, especially those hypointense in the hepatobiliary phase (HBP) without arterial phase hyperenhancement (APHE), present ...
Update on the STING signaling pathway in developing nonalcoholic fatty liver disease
2024-05-24
Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent chronic liver condition worldwide, affecting about 25% of the global population due to the increasing rates of obesity and metabolic syndrome. NAFLD encompasses a spectrum of liver conditions ranging from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH), which can progress to fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Despite its prevalence, there are limited effective treatment options available. Inflammation driven by metabolic disturbances is a key factor in the development and progression of ...
Autonomous medical intervention extends ‘golden hour’ for traumatic injuries with emergency air transport
2024-05-24
For the first time, a closed loop, autonomous intervention nearly quadrupled the “golden hour” during which surgeons could save the life of a large animal with internal traumatic bleeding while in emergency ground and air transport.
This breakthrough in trauma care, announced today in Intensive Care Medicine Experimental by physician-scientists at the University of Pittsburgh School of Medicine and funded by the U.S. Department of Defense, has enormous potential for saving the lives of traumatically injured ...
More than spins: Exploring uncharted territory in quantum devices
2024-05-24
Many of today’s quantum devices rely on collections of qubits, also called spins. These quantum bits have only two energy levels, the ‘0’ and the ‘1’. However, spins in real devices also interact with light and vibrations known as bosons, greatly complicating calculations. In a new publication in Physical Review Letters, researchers in Amsterdam demonstrate a way to describe spin-boson systems and use this to efficiently configure quantum devices in a desired state.
Quantum devices use the quirky behaviour of quantum ...
SG ramps up cancer fight with S$50 million in national grant funding for precision oncology
2024-05-24
Singapore, 24 May 2024 – Two multi-institution and multidisciplinary Singapore teams of clinician-scientists and researchers have been awarded grants of S$25 million each, by the Singapore Ministry of Health through the NMRC Office, MOH Holdings Pte Ltd, under the NMRC Open Fund-Large Collaborative Grant (OF-LCG) programme. The S$50 million support for cancer research establishes the SYMPHONY 2.0 and Colo-SCRIPT research programmes to drive precision oncology research in Singapore aimed at improving the understanding, diagnosis and treatment of lymphoma and colorectal cancer.
Led by the ...
Autophagy in pancreatitis
2024-05-24
Researchers are exploring a new potential avenue for pancreatitis treatment: autophagy, a cellular recycling process. Autophagy helps maintain healthy pancreatic acinar cells by removing damaged organelles like mitochondria and the endoplasmic reticulum (ER).
A new review published in eGastroenterology highlights the link between defective autophagy and pancreatitis. Impaired autophagy contributes to pancreatitis by allowing damaged organelles to accumulate within acinar cells. This accumulation disrupts cellular function and can ultimately lead to cell death.
"Autophagy plays a vital role in keeping pancreatic acinar cells healthy," ...
To 6G and beyond: Penn engineers unlock the next generation of wireless communications
2024-05-24
In the early 2010s, LightSquared, a multibillion-dollar startup promising to revolutionize cellular communications, declared bankruptcy. The company couldn’t figure out how to prevent its signals from interfering with those of GPS systems.
Now, Penn Engineers have developed a new tool that could prevent such problems from ever happening again: an adjustable filter that can successfully prevent interference, even in higher-frequency bands of the electromagnetic spectrum.
“I ...
USF researcher using VR to map the brain, understand and treat disorders such as autism
2024-05-24
TAMPA, Fla. (May 24, 2024) – Through high-tech imaging and virtual reality, a University of South Florida medical engineering professor is creating a detailed map of the brain that can be used to better understand developmental disorders, such as autism, and provide earlier, more effective treatments for brain injuries and diseases.
Funded by a $3.3 million grant from the National Institutes of Health, George Spirou is expanding on his four decades of brain research to focus on the part of the brain that ...
Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals
2024-05-24
Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals
A pioneering study has demonstrated that semaglutide significantly reduces the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients with type 2 diabetes and chronic kidney disease.1 The landmark trial, presented today at the 61st ERA Congress, will pave the way for new treatment strategies and ...